This model has been used to evaluate angiogenic factors such as VEGF, angiopoietin-2, basic fibroblast growth factor and candidate angiogenesis inhibitors that target tumor vasculature [1], [2], [5], [27]. The gene discussed is VEGFA; the disease is neoplasm.